|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Neurocrine Biosciences (NASDAQ: NBIX) through any online brokerage.
The latest price target for Neurocrine Biosciences (NASDAQ: NBIX) was reported by Morgan Stanley on May 6, 2021. The analyst firm set a price target for 116.00 expecting NBIX to rise to within 12 months (a possible 13.96% upside). 25 analyst firms have reported ratings in the last year.
The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $101.79 last updated Mon Jun 21 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Neurocrine Biosciences.
There is no upcoming split for Neurocrine Biosciences.
Neurocrine Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.